Atlas Trials

Efficacy and Safety Study of PEX168 in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin

Clinical trial NCT02477969 · UNKNOWN

Trial details

NCT number
NCT02477969
Sponsor
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2014-02-27
Primary completion
2016-06-22
Enrollment
587

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.